Windlas Biotech Limited (WINDLAS) — Financial Results | 24 July 2026
No summary available
About Windlas Biotech Limited (WINDLAS)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when WINDLAS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track WINDLAS — Free💡 Ask AI about this filing
📊 More WINDLAS filings
- Announcement — 11 August 2026 Windlas Biotech announced that the audio recording of its investor conference call discussing unaudi...
- Announcement — 10 August 2026 Windlas Biotech reported 18% YoY revenue growth to Rs 248 crore in Q1 FY27, driven by 84% contributi...
- 🔴 Financial Results — 10 August 2026 Windlas Biotech Limited reported record Q1 FY27 revenue of **₹248 crores**, up 18% YoY, driven by st...
- 🟡 Board Meeting — 10 August 2026 Windlas Biotech's board approved unaudited Q1 FY26 results showing revenue of **₹2,532.12 crores**, ...
- 🟡 Board Meeting — 23 July 2026 Windlas Biotech held its 25th Annual General Meeting on July 23, 2026 via video conference, with 63 ...
🔥 Also filed on 24 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when WINDLAS files new disclosures
Track WINDLAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track WINDLAS — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research